Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04281485
Brief Title: A Phase 3 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

First Submitted : February 11, 2020
First Submitted that Met QC Criteria : February 20, 2020
First Posted : February 24, 2020

Last Update Submitted that Met QC Criteria : April 2, 2021
Last Update Posted : April 5, 2021